Antonio Bellasi
Overview
Explore the profile of Antonio Bellasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
2273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salera D, Merkel N, Bellasi A, de Borst M
Clin Kidney J
. 2025 Mar;
18(Suppl 1):i3-i14.
PMID: 40083952
Chronic kidney disease-mineral bone disorder (CKD-MBD) is a multifaceted condition commonly seen in people with reduced kidney function. It involves a range of interconnected issues in mineral metabolism, bone health...
2.
Salera D, Bellasi A, Del Vecchio L, Locatelli F
Expert Opin Pharmacother
. 2024 Dec;
26(1):85-100.
PMID: 39676576
Introduction: Hyperphosphatemia in advanced CKD often accompanies high PTH and FGF23 levels, impaired bone mineralization, ectopic calcifications, and increased cardiovascular risks. Novel treatments are now available to lower serum phosphorus...
3.
La Porta E, Faragli A, Herrmann A, Lo Muzio F, Estienne L, Nigra S, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518641
Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic...
4.
Marando M, Tamburello A, Salera D, Di Lullo L, Bellasi A
Nephrology (Carlton)
. 2024 Oct;
29(12):791-800.
PMID: 39433296
Chronic kidney disease-mineral bone disorder (CKD-MBD) is a syndrome commonly observed in subjects with impaired renal function. Phosphate metabolism has been implicated in the pathogenesis of CKD-MBD and according to...
5.
Baumberger J, Dinges S, Lupi E, Wolters T, Stussi-Helbling M, Cippa P, et al.
ESC Heart Fail
. 2024 Sep;
12(1):688-694.
PMID: 39239801
Aims: Diuretic resistance (i.e., insufficient diuretic and natriuretic response to an appropriate dose of intravenously administered loop diuretic) is a major cause of insufficient decongestion in acute heart failure (AHF)....
6.
Treglia G, Albano D, Rizzo A, Bellasi A, Glaudemans A, Gheysens O
Diagnostics (Basel)
. 2024 Aug;
14(15).
PMID: 39125479
Background: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([F]FDG PET/CT) has been suggested as a useful imaging method for diagnosing cyst infections in patients with autosomal dominant polycystic kidney disease (ADPKD)....
7.
Taskapan H, Mahdavi S, Bellasi A, Martin S, Kuvadia S, Patel A, et al.
Clin Kidney J
. 2024 Jul;
17(7):sfae188.
PMID: 39070948
Background: Fibroblast growth factor 23 (FGF-23) and other markers of chronic kidney disease-mineral and bone disorder (CKD-MBD) provide valuable insights into disease processes, treatment options and patient prognosis. However, limited...
8.
Papillary necrosis, fluid intake, and sickle cell nephropathy: lessons for the clinical nephrologist
Cozzo D, Pianca S, Ogna V, DArpa S, Cippa P, Bellasi A
J Nephrol
. 2024 Jul;
38(1):271-274.
PMID: 38990266
No abstract available.
9.
Di Lullo L, Salera D, Galderisi C, Bellasi A
Int Urol Nephrol
. 2024 Jul;
56(12):3935.
PMID: 38954133
No abstract available.
10.
Cozzo D, Merkel N, Bellasi A
Int Urol Nephrol
. 2024 Jun;
56(11):3679-3681.
PMID: 38884684
No abstract available.